Early Aldo Blockade in Subclinical PA

Clinical trial NCT07727252 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07727252
Sponsor: Xinjiang Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Subclinical Primary Aldosteronism

Start date: 2026-08-01
Primary completion: 2029-08-01
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.